Browsing by Author SOO KHEE CHEE

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 4 to 14 of 14 < previous 
Issue DateTitleAuthor(s)
2011First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneumYu W. ; Chan-On W.; Teo M. ; Ong C.K.; Cutcutache I. ; Allen G.E.; Wong B. ; Myint S.S.; Lim K.H.; Voorhoeve P.M. ; Rozen S. ; Soo K.C. ; Tan P. ; Teh B.T. 
2015Mammographic breast density and common genetic variants in breast cancer risk predictionLee C.P.L.; Choi H. ; Soo K.C. ; Tan M.-H.; Chay W.Y.; Chia K.S. ; Liu J. ; Li J. ; Hartman M. 
2008Molecular profiling of angiogenesis in hypericin mediated photodynamic therapyBhuvaneswari R.; Gan Y.K.; Lucky S.S. ; Chin W.W.L.; Ali S.M. ; Soo K.C. ; Olivo M. 
10-Mar-2014Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinomaChow, P.K.H. ; Poon, D.Y.H.; Khin, M.-W.; Singh, H.; Han, H.-S.; Goh, A.S.W.; Choo, S.-P.; Lai, H.-K.; Lo, R.H.G.; Tay, K.-H.; Lim, T.-G.; Gandhi, M.; Tan, S.-B. ; Soo, K.-C. 
2003Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosisHuynh H. ; Tuyen Nguyen T.T.; Pierce Chow K.-H. ; Tan P.H. ; Soo K.C. ; Tran E.
2007Primary malignant melanoma of the esophagus with multiple esophageal lesionsHo, K.Y. ; Cheng, J.; Wee, A. ; Soo, K.C. 
2007Primary malignant melanoma of the esophagus with multiple esophageal lesionsHo, K.Y. ; Cheng, J.; Wee, A. ; Soo, K.C. 
2007Primary malignant melanoma of the esophagus with multiple esophageal lesionsHo, K.Y. ; Cheng, J.; Wee, A. ; Soo, K.C. 
2016Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal CarcinomatosisNg J.L. ; Ong W.S.; Chia C.S. ; Tan G.H.C. ; Soo K.-C. ; Teo M.C.C. 
2016Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): Study protocol for a phase iii randomized controlled trialGandhi M.; Choo S.P.; Thng C.H.; Tan S.B.; Low A.S.C.; Cheow P.C.; Goh A.S.W.; Tay K.H.; Lo R.H.G.; Goh B.K.P.; Wong J.S.; Ng D.C.E.; Soo K.C. ; Liew W.M.; Chow P.K.H.
2009Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor responseBhuvaneswari R.; Gan Y.Y.; Soo K.C. ; Olivo M.